April 24, 2024 Google’s Third Cookie Phaseout Delay Amid Regulatory Hurdles
April 19, 2024 Bitcoin Halving: Catalyst for New Price Heights?
Amazon: The Margin Train Is Gaining Speed
Amazon Web Services Expands Bedrock GenAI Service
Why Microsoft Stands Out As A Pre-Earnings Buy
Wall Street Lunch: Big Tech Bearishness?
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
Pfizer (PFE) stock Forecast for 2026
Updated: April 24, 2024 (09:40)
Sector: HealthcareThe share price of Pfizer Inc. (PFE) now
50/200 Day Moving Average: $27.08 / $30.69
This figure corresponds to the Average Price over the previous 50/200 days. For Pfizer stocks, the 50-day moving average is the resistance level today.
For Pfizer stocks, the 200-day moving average is the resistance level today.
Are you interested in Pfizer Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Pfizer stock price in 2026. How much will one Pfizer share be worth in 2026? Is it worth taking profit / loss on PFE stock now or waiting? What are analysts' forecasts for Pfizer stock?
We forecast Pfizer stock performance using neural networks based on historical data on PFE stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Pfizer Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Pfizer analysts is $31.1. Today 200 Day Moving Average is the resistance level (30.69 $). 50 Day Moving Average is the support level (27.08 $).
Historical and forecast chart of Pfizer Inc. stock
The chart below shows the historical price of Pfizer stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the PFE stock price can be found in the table below.
Sell or Buy Pfizer (PFE) stocks? Analytic Experts Forecasting...
Pfizer: Seagen Acquisition Starting To Bear Fruit
The Bright Future Awaiting Pfizer Stocks in 2026: A Predictive Outlook
Pfizer Inc. (NYSE:PFE), a giant in the pharmaceutical industry, presents an intriguing case for investors, especially when forecasting its stock performance leading up to 2026. Predicting PFE stock rates, like any investment in the stock market, carries its own uncertainties. The precision of such forecasts hinges on various dynamic factors, including market sentiment, global healthcare trends, and the company’s operational execution. However, by dissecting Pfizer’s current trajectory and planned strategic moves, we can get a glimpse into its potential financial health in 2026.
Key Influencers on Pfizer’s 2026 Stock Performance
Several prime factors will likely shape the future of PFE stock rates. Firstly, Pfizer’s robust product pipeline, including the advancement of Antibody-Drug Conjugates (ADC) and other innovative therapies, positions the company well ahead of the patent cliff facing some of its key drugs. This diverse pipeline, leveraging the financial windfall from its COVID-19 related products, enables Pfizer to potentially usher in a new era of growth.
Additionally, Pfizer’s strategic acquisition of Seagen, a market leader in the ADC sector, paid for with COVID revenues, represents the company’s aggressive pursuit of next-generation therapies. This move underpins Pfizer’s strategic foresight and signifies a pivotal growth vector influencing the PFE stock forecast.
As for the PFE stock price target, the projected EPS growth and rising EBITDA margins indicate a promising upward trajectory. Conservative estimates previously calculated a growth potential of 20.8% by 2024 and 50.2% by 2025. Extending this optimistic outlook further into 2026, while speculative, suggests that PFE stock could indeed ascend higher, reinforcing a “buy” sentiment among investors questioning, “will PFE stock go up?”
In conclusion, while predicting the exact PFE price stock in 2026 embodies inherent uncertainties, Pfizer’s strategic assets—spanning its innovative pipeline, acquisition-led growth, and financial resilience—lay a strong foundation for optimistic Pfizer stock price forecasts. Investors eyeing the Pfizer stock forecast should weigh these facets, recognizing the blend of opportunities and challenges that will define PFE’s journey in the years leading to 2026.
Pfizer (PFE) Forecast for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 26.47 | 24.77 | 27.42 | 9.64 % |
| Feb | 26.61 | 25.00 | 28.26 | 11.52 % |
| Mar | 27.11 | 26.04 | 27.92 | 6.73 % |
| Apr | 28.70 | 27.85 | 29.76 | 6.42 % |
| May | 27.95 | 26.04 | 28.78 | 9.53 % |
| Jun | 27.52 | 26.46 | 28.19 | 6.15 % |
| Jul | 27.60 | 26.58 | 28.59 | 7.04 % |
| Aug | 28.14 | 27.13 | 29.69 | 8.62 % |
| Sep | 27.56 | 25.92 | 29.22 | 11.29 % |
| Oct | 26.52 | 25.23 | 28.14 | 10.35 % |
| Nov | 25.18 | 23.64 | 25.79 | 8.35 % |
| Dec | 26.11 | 25.36 | 27.43 | 7.54 % |
Pfizer information and performance
235 E 42ND ST, NEW YORK, NY, US
Market capitalization of the Pfizer Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of PFE shares in the company outstanding by the market price of one share.
EBITDA of Pfizer is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Pfizer price target for 2026 by month
Target values for the price of one Pfizer share for Jan 2026.
In Jan, the Negative dynamics for Pfizer Inc. shares will prevail with possible monthly volatility of 9.643% volatility is expected.
Pessimistic target level: 24.77
Optimistic target level: 27.42
Target values for the price of one Pfizer share for Feb 2026.
In Feb, the Positive dynamics for Pfizer Inc. shares will prevail with possible monthly volatility of 11.525% volatility is expected.
Pessimistic target level: 25.00
Optimistic target level: 28.26
Target values for the price of one Pfizer share for Mar 2026.
In Mar, the Positive dynamics for Pfizer Inc. shares will prevail with possible monthly volatility of 6.730% volatility is expected.
Pessimistic target level: 26.04
Optimistic target level: 27.92
Target values for the price of one Pfizer share for Apr 2026.
In Apr, the Positive dynamics for Pfizer Inc. shares will prevail with possible monthly volatility of 6.423% volatility is expected.
Pessimistic target level: 27.85
Optimistic target level: 29.76
Target values for the price of one Pfizer share for May 2026.
In May, the Negative dynamics for Pfizer Inc. shares will prevail with possible monthly volatility of 9.527% volatility is expected.
Pessimistic target level: 26.04
Optimistic target level: 28.78
Target values for the price of one Pfizer share for Jun 2026.
In Jun, the Negative dynamics for Pfizer Inc. shares will prevail with possible monthly volatility of 6.150% volatility is expected.
Pessimistic target level: 26.46
Optimistic target level: 28.19
Target values for the price of one Pfizer share for Jul 2026.
In Jul, the Positive dynamics for Pfizer Inc. shares will prevail with possible monthly volatility of 7.037% volatility is expected.
Pessimistic target level: 26.58
Optimistic target level: 28.59
Target values for the price of one Pfizer share for Aug 2026.
In Aug, the Positive dynamics for Pfizer Inc. shares will prevail with possible monthly volatility of 8.617% volatility is expected.
Pessimistic target level: 27.13
Optimistic target level: 29.69
Target values for the price of one Pfizer share for Sep 2026.
In Sep, the Negative dynamics for Pfizer Inc. shares will prevail with possible monthly volatility of 11.289% volatility is expected.
Pessimistic target level: 25.92
Optimistic target level: 29.22
Target values for the price of one Pfizer share for Oct 2026.
In Oct, the Negative dynamics for Pfizer Inc. shares will prevail with possible monthly volatility of 10.347% volatility is expected.
Pessimistic target level: 25.23
Optimistic target level: 28.14
Target values for the price of one Pfizer share for Nov 2026.
In Nov, the Negative dynamics for Pfizer Inc. shares will prevail with possible monthly volatility of 8.347% volatility is expected.
Pessimistic target level: 23.64
Optimistic target level: 25.79
Target values for the price of one Pfizer share for Dec 2026.
In Dec, the Positive dynamics for Pfizer Inc. shares will prevail with possible monthly volatility of 7.540% volatility is expected.
Pessimistic target level: 25.36
Optimistic target level: 27.43
Pfizer (PFE) stock dividend
Pfizer last paid dividends on 01/25/2024. The next scheduled payment will be on 03/01/2024. The amount of dividends is $1.64 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
